Growth Metrics

Avai Bio (AVAI) Shares Outstanding (2018 - 2025)

Avai Bio's Shares Outstanding history spans 7 years, with the latest figure at $117.2 million for Q1 2024.

  • On a quarterly basis, Shares Outstanding rose 204.3% to $117.2 million in Q1 2024 year-over-year; TTM through Mar 2024 was $117.2 million, a 204.3% increase, with the full-year FY2024 number at $117.2 million, up 204.3% from a year prior.
  • Shares Outstanding hit $117.2 million in Q1 2024 for Avai Bio, up from $84.8 million in the prior quarter.
  • Over the last five years, Shares Outstanding for AVAI hit a ceiling of $117.2 million in Q1 2024 and a floor of $1.1 million in Q1 2020.
  • Historically, Shares Outstanding has averaged $43.0 million across 5 years, with a median of $29.3 million in 2022.
  • Biggest five-year swings in Shares Outstanding: tumbled 78.78% in 2020 and later skyrocketed 2369.89% in 2021.
  • Tracing AVAI's Shares Outstanding over 5 years: stood at $26.3 million in 2020, then changed by 0.0% to $26.3 million in 2021, then grew by 22.64% to $32.2 million in 2022, then surged by 163.08% to $84.8 million in 2023, then skyrocketed by 38.18% to $117.2 million in 2024.
  • Business Quant data shows Shares Outstanding for AVAI at $117.2 million in Q1 2024, $84.8 million in Q4 2023, and $74.3 million in Q3 2023.